Healthcare technology company Craneware has announced that revenue and profit continue to grow in its key US market.
The Edinburgh-based firm posted a 15% increase for the six month period to the end of December, building on a similar surge in the first half of the year.
Chief executive Keith Neilson said: “There is continued consensus in the US of the need to drive value in healthcare with ongoing support for the move to value-based care and increasing consumerism.
“An impending change of government always brings with it an element of uncertainty. It was therefore particularly pleasing to see the acceleration in sales of our ‘Value Cycle’ solutions post the result of the US Presidential election.
“[The] software continues to help US healthcare providers meet the challenges they will face as they navigate the ongoing re-imbursement model changes.”
The company is investing $3m in an employee benefit trust and $1m in product development, as well as looking at “strategic opportunities” with the aid of a $50m funding facility from the Bank of Scotland.